Stephen E. Gould - Feb 9, 2023 Form 4 Insider Report for Atreca, Inc. (BCEL)

Role
Chief Scientific Officer
Signature
/s/ Courtney Phillips, Attorney-In-Fact
Stock symbol
BCEL
Transactions as of
Feb 9, 2023
Transactions value $
$0
Form type
4
Date filed
2/13/2023, 07:53 PM
Previous filing
Jun 17, 2022
Next filing
Aug 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCEL Class A Common Stock Award $0 +32.5K $0.00 32.5K Feb 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCEL Employee stock option (right to buy) Award $0 +130K $0.00 130K Feb 9, 2023 Class A Common Stock 130K $1.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an award of 32,500 restricted stock units on February 9, 2023, vesting in three equal annual installments beginning on August 1, 2023. Each restricted stock unit represents a right to receive one share of Atreca Class A Common Stock upon vesting.
F2 1/48 of the Option vests in equal monthly installments as measured from January 1, 2023. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.